SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma.
Zuyi MaZhenchong LiShujie WangQi ZhouZuguang MaChunsheng LiuBowen HuangZehao ZhengLinLing YangYiping ZouChuanzhao ZhangShanzhou HuangBao-Hua HouPublished in: Journal of hepatocellular carcinoma (2021)
An increased SLC39A10 expression was found and served as an unfavorable indicator of survival in HCC. Further studies suggested SLC39A10 promotes tumor aggressiveness and may provide a novel target for HCC therapy.